Jeuveau and Botox are both botulinum toxin type A injectables — they relax facial muscles to soften dynamic wrinkles. Both are FDA-approved. At a cellular level, they work identically. Elements uses Jeuveau as our primary neuromodulator for two reasons: (1) it was developed exclusively for aesthetic use (Botox was originally developed for medical conditions); (2) the Evolus savings program offers $40 off Jeuveau and $40 off filler — savings you can't get with Botox. Most patients can't tell the difference in result.
Honest assessment: most patients can't tell the difference in result between Jeuveau and Botox. Both are botulinum toxin type A. Both have similar onset (3–7 days), similar peak (14 days), similar duration (3–4 months). The differences are practical: Jeuveau is positioned exclusively for aesthetic use; Botox has a longer history and broader brand recognition. The Evolus savings program is the most patient-friendly part — $40 off neuromodulator + $40 off filler at every visit, ongoing. We treat all the standard areas (forehead, glabellar 11s, crow's feet, lip flip, masseter for jaw slimming, brow lift, neck bands) with the same precision approach regardless of which product. If you have a strong preference for Botox, we can stock it for specific patients; in practice, almost no one switches once they've experienced Jeuveau's pricing.
Key Benefits
Recent results
Real jeuveau vs botox — which is right for you? outcomes.
A selection of recent patient outcomes by Sharon Maxwell, NP-C. Every patient pictured consented to share. The Elements approach: enhancement, never overdone.
Individual results vary. All patients pictured consented to share their results. Photographs are unretouched. Sessions performed by Sharon Maxwell, NP-C at Elements Med Lounge, Draper, Utah.
Side-by-side
Jeuveau vs Botox
Head-to-head specifications for the two most common neuromodulators we use at Elements.
| Property | Jeuveau | Botox |
|---|---|---|
| Active ingredient | prabotulinumtoxinA-xvfs | onabotulinumtoxinA |
| FDA approval | 2019 (cosmetic) | 1989 medical · 2002 cosmetic |
| Indication scope | Aesthetic only | Aesthetic + medical (TMJ, migraine, hyperhidrosis) |
| Onset | 3–5 days | 3–5 days |
| Peak effect | Day 14 | Day 14 |
| Typical duration | 3–4 months | 3–4 months |
| Glabellar dose (avg) | 20 units | 20 units |
| Manufacturer program | Evolus Rewards · $40 off Jeuveau + $40 off filler each visit | Allē points (no Elements stacked discount) |
Both products are botulinum toxin type A. In head-to-head trials (EVB-003), the agents performed equivalently on duration, onset, and patient satisfaction.
Common questions
Frequently asked
Is Jeuveau or Botox better?
Honestly: most patients can't tell the difference in result. Both are botulinum toxin type A. Both have similar onset (3–7 days), peak (14 days), and duration (3–4 months). The differences are practical: Jeuveau was developed exclusively for aesthetics; Botox has a longer history and broader brand recognition.
Why does Elements use Jeuveau as primary?
Two reasons: (1) Jeuveau was developed exclusively for aesthetic use (Botox was originally developed for medical conditions and adapted for cosmetics); (2) the Evolus savings program offers $40 off Jeuveau and $40 off filler — savings you can't get with Botox.
Is the Evolus savings program ongoing?
Yes — $40 off Jeuveau and $40 off filler is available at every visit, ongoing. It's not a one-time promotion. Patients who get both Jeuveau and filler save $80 per visit.
Will Jeuveau and Botox last the same amount of time?
In most patients, yes — typically 3–4 months. Some patients metabolize one faster than the other based on individual physiology. We track longevity at follow-up to optimize your dosing schedule.
Can I switch from Botox to Jeuveau or vice versa?
Yes. Many patients alternate or switch entirely. Both products work the same way at a cellular level, so your body doesn't "lose tolerance" or get a different result long-term.
Research & evidence
Supporting clinical research
Peer-reviewed sources informing our protocols. We update this list as new high-quality studies are published.
- Beer KR, Shamban AT, Avelar RL, Gross JE, Jonker A (2019). Efficacy and Safety of Prabotulinumtoxina for the Treatment of Glabellar Lines in Adult Subjects: Results from 2 Identical Phase III Studies. Dermatologic Surgery. View on PubMed →
- Carruthers J, Solish N, Humphrey S, et al. (2020). A Randomized, Double-Blind, Comparator-Controlled Study of Prabotulinumtoxina vs Onabotulinumtoxina for Glabellar Lines (EVB-003). Plastic and Reconstructive Surgery. View on PubMed →
Start here
Book now to discuss jeuveau vs botox — which is right for you? with the Elements team.
Book now